Increasingly scientific support for Bioservo's grip-strengthening glove

Report this content

Yet another study has been published that shows the positive effects of using Bioservo's technology to strengthen the grip of the hand. The latest study investigated the usefulness and effects of an assisted robotic glove in the home environment for people with MS or who got a stroke. This is the latest in a series of studies published this past year.


In this study *1, conducted in a collaboration between Karolinska Institutet and Danderyd's hospital, the effects of a variety of activities of daily living were investigated. The most positive effects were that people could hold onto things for a long time with a firm grip. One person with MS describes it like this: “The advantage has been that I have been able to use my left hand to lift things up and grab things. First grab and then lift… I couldn't do that before”. Another person said "The positive is that the glove helps with the grip and the negative is that I should have had it earlier before my ability disappeared."

The previously published article in the scientific journal "Journal of NeuroEngineering and Rehabilitation" *2 shows that home rehabilitation with Bioservo Technologies grip-strengthening glove leads to improved hand function for people with spinal cord injury. The conclusion from the study is that rehabilitation with the robotic glove is effective in improving and maintaining gross and fine motor function for people with spinal cord injury. In a previously published article in the scientific journal PLoS ONE *3, research results show that support for the soft grip-strengthening robotic glove, either as an aid or as a training tool, can be a promising way to counter the deterioration of hand function associated with aging.

We are still waiting for the results of the most comprehensive study that has not yet been completed. It examines the rehabilitative effect of using Bioservo's grip-strengthening glove.

Puzzle pieces are added one by one and build up an increasingly powerful picture that Bioservo's grip-strengthening glove not only helps people with impaired hands to cope with daily activities, but can also be used for rehabilitative purposes to regain lost hand function and counteract the deterioration of hand function associated with aging.

*1 Factors affecting the usability of an assistive soft robotic glove after stroke or multiple sclerosis. Susanne Palmcrantz, Jeanette Plantin, Jörgen Borg Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Rehabilitation Medicine, Stockholm, Sweden. Journal of Rehabilitation Medicine (march 2020)

*2 Osuagwu, B.A., Timms, S., Peachment, R. et al. Home-based rehabilitation using a soft robotic hand glove device leads to improvement in hand function in people with chronic spinal cord injury:a pilot study. J NeuroEngineering Rehabil 17, 40 (2020).

*3 Radder B, Prange-Lasonder GB, Kottink AIR, Holmberg J, Sletta K, van Dijk M, et al. (2019) Home rehabilitation supported by a wearable soft-robotic device for improving hand function in older adults: A pilot randomized controlled trial. PLoS ONE 14(8): e0220544.


For more information, please contact 

Petter Bäckgren, CEO, Bioservo Technologies AB
Phone: 08 21 17 10

Mikael Wester, Marketing Director, Bioservo Technologies AB
Phone: 08 21 17 10


About Bioservo Technologies

Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy and efficient.

The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength.

Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.


FNCA Sweden AB, +46(0)8 528 00399, is the Company’s Certified Adviser on Nasdaq First North Growth Market.
For more information, please visit